Adam Griesemer

Surgical Director, Pediatric Liver Transplant Program, Living Donor Liver Transplant Program
NYU Langone Health Transplant Institute
Adam Griesemer MD

Brief Bio

Adam Griesemer is an Assistant Professor of Surgery at Columbia University-Irving Medical Center. He grew up in St. Louis, Missouri and performed his undergraduate studies at Harvard College. He received his MD from the University of Missouri-Columbia in 2003. He then completed his surgical residency and transplant surgery training at Columbia University Medical Center in New York. He currently serves as the surgical director of the pediatric liver transplant and living donor liver transplant programs at Columbia. Dr. Griesemer also runs a research laboratory that studies transplant immunology in an effort to induce immunologic tolerance to organ transplants. He has received grant funding for his research from the NIH, American Society of Transplant Surgeons and the American Association for the Study of Liver Diseases.

Alliance Presentations

Healthy Liver. Human Hands Holding Liver Symbol On White Backgro

Preventing Pediatric Liver Waitlist Deaths: A Call to Action!

Wednesday, September 27, 2023, at 3:00pm

The Alliance Conversation Series brings you cost-free, fast-paced collaborative opportunities that highlight successful donation and transplantation practices across the country. Through shared insight, multidisciplinary experts identify solutions to critical challenges affecting the community of practice and actively share them for open discussion and broader knowledge of effective practices.

The sessions encourage real-time feedback and participation from viewers.

Overview: Children, especially those under 5 years of age, have the highest death rate on the transplant waiting list compared to any other age range. Countries like UK and Australia have been able to almost eliminate waitlist death of children through a combination of centralization of liver transplant services and an intention to split policy. In the US, despite the organ donation rates per million population exceeding that of the UK or Australia, deaths on the waiting list remains high. Pediatric liver transplantation waitlist mortality is a solvable problem, with the solution likely reachable by multiple pathways. An analysis led by University of Pittsburgh and collaborators from the Starzl Network for Excellence in Pediatric Transplantation ( suggests that greater use of partial liver transplants, either from a living donor or by splitting a deceased donor’s liver for two recipients, could save many of these young lives.

In this session, we will explore successful Australian pediatric liver transplant policy and practices and discuss opportunities for improvement in the US to achieving zero wait list mortality with ideal outcomes

Lifelong Networks

Our partners are the heart and soul of our organization. For more than 15 years, they have played a vital role providing quality education and programs to advance a shared mission.